The FDA has approved a new botulinum toxin formulation for aesthetic use in the US. Letybo from Hugel America, Inc., a division of Hugel Inc., is approved to treat moderate-to-severe glabellar (frown) lines in adults. Letybo (letibotulinumtoxinA-wlbg) is expected to...
By Joe Gorelick, MSN, FNP-C Individuality drives the definition of beauty for nearly three-quarters of Americans participating in a comprehensive survey by Allergan Aesthetics, an AbbVie. “Decoding the Future of Aesthetic Individuality” also reveals that...
What’s the difference between primary and secondary failure of a biologic? And why does it matter? Exploring an actual patient case, faculty from the DEF Biologic and Small Molecule NP/PA CME Bootcamp—April Armstrong, MD, MPH; David E. Cohen, MD, MPH; Kara Gooding,...
Day in and day out, dermatology care professionals face multiple decisions, record pages of medical data, and counsel patients on product selection and use. So what are the best ways to do these various tasks. Dermatology thought leaders share their recommendations in...
Medical and cosmetic dermatology often overlap, says dermatologist and DERM 2023 faculty member Gilly Munavalli, MD. Along with fellow faculty member Suneel Chilukuri, MD, he discussed basic aesthetic interventions that may be appropriate for most practices. They...
Kristine Kucera, PA-C, MPAS, DHS The popularity of sunless tanning has surged as people seek a healthier and safer sun-kissed glow without exposing themselves to the effects of ultraviolet (UV) radiation. Sunless tanning products contain an active...